Your session is about to expire
← Back to Search
Patients on a bone marrow transplant unit with an anticipated stay of two or more weeks for Pregnancies
N/A
Waitlist Available
Led By Kimberly P Kirklin, MA
Research Sponsored by University of Alabama at Birmingham
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Age >18
Inpatient on either Bone Marrow Transplant ICU or High Risk Obstetrics Unit
Timeline
Screening 3 weeks
Treatment Varies
Follow Up week 3 - weekly up to 10 weeks
Awards & highlights
Study Summary
This trial is testing whether a new way of giving radiation therapy to people with cancer in the brain is better than the standard way.
Who is the study for?
This trial is for adult patients hospitalized in the Bone Marrow Transplant ICU or High Risk Obstetrics Unit, expected to stay at least two weeks and can physically engage in arts activities like hand-sewing or storytelling/poetry. It's not suitable for those too ill, unwilling to participate, under 18, or with complex conditions that leave no time for participation.Check my eligibility
What is being tested?
The study is examining how participating in arts-based activities such as hand-sewing and storytelling/poetry affects the hospital experience of patients undergoing bone marrow transplants or high-risk pregnancies.See study design
What are the potential side effects?
Since this trial involves arts interventions rather than medical treatments, traditional side effects are not applicable. However, participants may experience emotional responses or fatigue related to engagement in these activities.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I am older than 18 years.
Select...
I am currently admitted in the Bone Marrow Transplant ICU or High Risk Obstetrics Unit.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ week 3 - weekly up to 10 weeks
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~week 3 - weekly up to 10 weeks
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Evaluate patient experience during the course of intervention using name of survey
Trial Design
4Treatment groups
Active Control
Group I: HRO Standard of CareActive Control1 Intervention
SOC
Group II: Patients on a bone marrow transplant unit with an anticipated stay of two or more weeksActive Control1 Intervention
patients in this group will receive twice weekly visits with a professional storyteller.
Group III: Patients on a high-risk obstetrics unit with an anticipated stay of two or more weeksActive Control1 Intervention
patients in this group will receive twice weekly sewing and embroidery interactions with a professional artist in residence.
Group IV: BMT Standard of CareActive Control1 Intervention
SOC
Find a Location
Who is running the clinical trial?
University of Alabama at BirminghamLead Sponsor
1,583 Previous Clinical Trials
2,279,944 Total Patients Enrolled
Kimberly P Kirklin, MAPrincipal InvestigatorUniversity of Alabama at Birmingham
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I am older than 18 years.I have a complex health condition that doesn't allow me to join the trial.You are too sick to participate.I have chosen not to participate.I am physically able to participate in hand-sewing activities.I can physically engage in storytelling or poetry.I am currently admitted in the Bone Marrow Transplant ICU or High Risk Obstetrics Unit.I am under 18 years old.Patients who may benefit from the study intervention.
Research Study Groups:
This trial has the following groups:- Group 1: HRO Standard of Care
- Group 2: Patients on a bone marrow transplant unit with an anticipated stay of two or more weeks
- Group 3: Patients on a high-risk obstetrics unit with an anticipated stay of two or more weeks
- Group 4: BMT Standard of Care
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Are researchers currently enrolling volunteers for this experiment?
"As indicated on clinicaltrials.gov, this trial is no longer looking for participants as it was initially posted in January 2019 and last modified February 2022. However, 24 other trials are presently open to prospective patients at the moment."
Answered by AI
Share this study with friends
Copy Link
Messenger